The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More

The CRISPR technology has partially restored vision to people with inherited blindness.

Scientists have presented the results of the first phase of clinical trials involving 14 people with inherited blindness, specifically Leber congenital amaurosis. Significant improvements in vision parameters have been observed with the application of CRISPR gene editing technology. Leber congenital amaurosis is characterized by a mutation in the CEP290 gene, resulting in severe vision loss,…

Read More

Brain Stimulation at 40 Hz Clears Signs of Alzheimer’s Disease

Scientists have identified a mechanism that initiates the process of clearing brain tissue from amyloid proteins through exposure to a 40 Hz frequency. These results point to the possibilities of a simple and effective therapy and prevention for various neurodegenerative diseases. In 2016, researchers from the Massachusetts Institute of Technology noticed the positive impact of…

Read More

Epigenetic Editing Potentially Lowers Cholesterol Levels Permanently

Scientists have presented the results of a remarkable preclinical study that employs an epigenetic approach instead of traditional gene editing. In this method, DNA sequences are not cut and replaced — instead, scientists merely adjust the activity of specific genes. This treatment has already led to the normalization of cholesterol levels in mice. Epigenetic editing…

Read More